Search

Your search keyword '"Salek-Ardakani S"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Salek-Ardakani S" Remove constraint Author: "Salek-Ardakani S"
96 results on '"Salek-Ardakani S"'

Search Results

1. Investigating the molecular basic of AMKL and MDS

3. Fc?RIIB engagement drives agonistic activity of Fc-engineered ?OX40 antibody to stimulate human tumor-infiltrating T cells

4. Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung during Respiratory Syncytial Virus Infection

7. A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients With Locally Advanced or Metastatic Cancers

8. Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

9. Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications.

10. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade.

11. A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers.

12. Combinatorial immunotherapy induces tumor-infiltrating CD8 + T cells with distinct functional, migratory, and stem-like properties.

13. EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8 + T Cells.

14. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.

15. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.

16. Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment.

17. CD8 + T Cell Exhaustion in Cancer.

18. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.

19. EZH2 as a Regulator of CD8+ T Cell Fate and Function.

20. Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody.

21. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.

24. CD40 agonist-induced IL-12p40 potentiates hepatotoxicity.

25. Lack of B Lymphocytes Enhances CD8 T Cell-Mediated Resistance against Respiratory Viral Infection but Compromises Memory Cell Formation.

26. CD200R1 regulates eosinophilia during pulmonary fungal infection in mice.

27. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis.

28. Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-OX40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity.

29. Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.

30. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.

31. Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab.

32. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells.

33. Batf3-Dependent Dendritic Cells Promote Optimal CD8 T Cell Responses against Respiratory Poxvirus Infection.

34. The TNF Superfamily Molecule LIGHT Promotes the Generation of Circulating and Lung-Resident Memory CD8 T Cells following an Acute Respiratory Virus Infection.

35. Inflammatory monocytes contribute to the persistence of CXCR3 hi CX3CR1 lo circulating and lung-resident memory CD8 + T cells following respiratory virus infection.

36. HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

37. Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection.

38. Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses.

39. Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity.

40. OX40 Cooperates with ICOS To Amplify Follicular Th Cell Development and Germinal Center Reactions during Infection.

41. Tissue-specific programming of memory CD8 T cell subsets impacts protection against lethal respiratory virus infection.

42. Rapid control of pandemic H1N1 influenza by targeting NKT-cells.

43. Transcription Factor Bcl11b Controls Effector and Memory CD8 T cell Fate Decision and Function during Poxvirus Infection.

44. The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation.

45. α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.

46. C-Myc regulation by costimulatory signals modulates the generation of CD8+ memory T cells during viral infection.

47. Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation.

48. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

49. Macrophage adaptation in airway inflammatory resolution.

50. Targeted disruption of CD1d prevents NKT cell development in pigs.

Catalog

Books, media, physical & digital resources